Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Jones

Showing results (211-220 of 214) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 214 results.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Ecancermedicalscience|October 21, 2020
The care of older cancer patients in the United KingdomFabio Gomes, Anna Lewis, Rob Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2022
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Pageof 22

Showing results (211-220 of 214) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 214 results.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Ecancermedicalscience|October 21, 2020
The care of older cancer patients in the United KingdomFabio Gomes, Anna Lewis, Rob Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2022
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Pageof 22